Episode Synopsis "Pathophysiology and Pharmacologic Rationale of Emerging Agents for the Treatment of PTSD "

Guest: Roger McIntyre, MD Guest: Joseph F. Goldberg, MD Patients with PTSD suffer from a range of psychiatric symptoms that severely reduce their quality of life. PTSD has proven to not only be a complicated diagnosis, but also one that has a low index of suspicion. Many patients are not screened for PTSD, and those who are diagnosed often gain little benefit from currently available treatments. Join us as these issues are dissected by Drs. Joseph Goldberg and Roger McIntyre, with the objective of providing clinicians with key action steps to take to improve outcomes for patients affected by PTSD.

Listen "Pathophysiology and Pharmacologic Rationale of Emerging Agents for the Treatment of PTSD "

More episodes of the podcast Psychiatry and Mental Health

• The Safety of Sodium Oxybate in Treating Narcolepsy
• Setting the Stage: Unmet Needs in the Treatment of Women With PTSD
• Prevalence and Burden of PTSD in Women: Focus on Factors That Affect Patient Presentation, Such as Race, Risk Factors, Stigma, and Other Drivers
• Role of PCP & Ob-Gyn With Women at Risk for PTSD: Recognition, Screening, and Referral
• Proactively Uncovering Potential Traumatic Experiences Linked to Patient Psychiatric Symptoms in Women
• Conversations With Patients About PTSD, Screening, and Referral
• Inconsistent Outcomes: How Ignoring Guidelines Leads to Unpredictable Results
• Limitations of Current Treatments: FDA-Approved and Off-Label Approaches
• Pathophysiology and Pharmacologic Rationale of Emerging Agents for the Treatment of PTSD
• Profile and Role of Emerging Treatment Options: MOA, Safety and Efficacy, and Identifying the Patients Who May Benefit
• Modeling Activity: Quality Conversations With Patients About Suboptimal Management of PTSD Symptoms and Emerging Treatment Options